Label changed on Biogen's top MS drug to reflect patient death

Investors appeared unphased today after news that the labeling for Biogen Idec's blockbuster multiple sclerosis drug will be updated to reflect the death of one patient from a rare brain disease which is possibly related to the use of the drug...